What's in Universiti Sains Malaysia's pipeline?

Universiti Sains Malaysia has 5 drugs in our index: 3 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Universiti Sains Malaysia's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universiti-sains-malaysia.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Universiti Sains Malaysia — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Universiti Sains Malaysia pipeline: 3 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 1 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
Topical Gutt Nepafenac 0.1%	Topical Gutt Nepafenac 0.1%	marketed
Empirical therapy group	Empirical therapy group	marketed
Stingless bee honey (Kelulut)	Stingless bee honey (Kelulut)	marketed	Natural product / botanical extract	Wound healing, Immunology, Gastroenterology
paliparidone	paliparidone	phase 3		Other

Therapeutic area mix

Other · 2
Wound healing, Immunology, Gastroenterology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Universiti Sains Malaysia:

Cite this brief

Drug Landscape (2026). Universiti Sains Malaysia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universiti-sains-malaysia. Accessed 2026-05-16.